CysLT1 receptor-induced human airway smooth muscle cells proliferation requires ROS generation, EGF receptortransactivation and ERK1/2 phosphorylation

Respiratory Research

Volumn 7, Issue , 2006, Pages

  Ravasi, Saula ^a   Citro, Simona ^a   Viviani, Barbara ^a   Capra, Valérie ^a   Rovati, G Enrico ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; DICHLORODIHYDROFLUORESCEIN DIACETATE; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; GUANOSINE TRIPHOSPHATASE; HISTONE H3; LEUKOTRIENE D4; LEUKOTRIENE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MONOCLONAL ANTIBODY; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; POLYCLONAL ANTIBODY; PROTEIN KINASE; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; ANDROSTANE DERIVATIVE; CHROMONE DERIVATIVE; ENZYME INHIBITOR; LEUKOTRIENE D4 RECEPTOR; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MORPHOLINE DERIVATIVE; PROTEIN KINASE INHIBITOR; SCAVENGER; WORTMANNIN;

ARTICLE; BREATHING MUSCLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; MITOGENICITY; OXIDATION; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRANSACTIVATION; BIOSYNTHESIS; BRONCHUS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; TRANSCRIPTION INITIATION;

ACETYLCYSTEINE; ANDROSTADIENES; BRONCHI; CELL PROLIFERATION; CELLS, CULTURED; CHROMONES; DNA; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FREE RADICAL SCAVENGERS; HUMANS; LEUKOTRIENE D4; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MORPHOLINES; MYOCYTES, SMOOTH MUSCLE; PERTUSSIS TOXIN; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RAS PROTEINS; REACTIVE OXYGEN SPECIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, LEUKOTRIENE; TRANSCRIPTIONAL ACTIVATION;

EID: 33745684429     PISSN: 1465993X     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-7-42     Document Type: Article

References (58)

1. Nicosia S, Capra V, Rovati GE: Leukotrienes as mediators of asthma. Pulm Pharmacol Ther 2001, 14(1):3-19.
2. Drazen JM: Leukotrienes in asthma. Adv Exp Med Biol 2003, 525:1-5.
3. Halayko AJ, Amrani Y: Mechanisms of inflammation-mediated airway smooth muscle plasticity and airways remodeling in asthma. Respir Physiol Neurobiol 2003, 137(2-3):209-222.
4. Hamid Q, Tulic MK, Liu MC, Moqbel R: Inflammatory cells in asthma: mechanisms and implications for therapy. J Allergy Clin Immunol 2003, 111(1 Suppl):S5-S12. discussion S12-17
5. Black JL, Johnson PR: Factors controlling smooth muscle proliferation and airway remodelling. Curr Opin Allergy Clin Immunol 2002, 2(1):47-51.
6. Hamid Q: Airway remodeling in asthma. J Allergy Clin Immunol 2003, 111(6):1420-1421.
7. Jeffery PK: Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001, 164(10 Pt 2):S28-38.
8. Johnson PR, Roth M, Tamm M, Hughes M, Ge Q, King G, Burgess JK, Black JL: Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med 2001, 164(3):474-477.
9. Benayoun L, Druilhe A, Dombret MC, Aubier M, Pretolani M: Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 2003, 167(10):1360-1368.
10. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB: Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989, 140(6):1745-1753.
11. Holgate ST, Peters-Golden M, Panettieri RA, Henderson WR Jr: Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 2003, 111(1B):S18-S36.
12. Billington CK, Penn RB: Signaling and regulation of G protein-coupled receptors in airway smooth muscle. Respir Res 2003, 4(1):2.
13. Fahy JV, Corry DB, Boushey HA: Airway inflammation and remodeling in asthma. Curr Opin Pulm Med 2000, 6(1):15-20.
14. 4 on human airway smooth muscle cell proliferation, matrix expression, and contraction In vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. Am J Respir Cell Mol Biol 1998, 19(3):453-461.
15. Espinosa K, Bosse Y, Stankova J, Rola-Pleszczynski M: CysLT1 receptor upregulation by TGF-beta and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4. J Allergy Clin Immunol 2003, 111(5):1032-1040.
16. Drazen JM, Israel E, O'Byrne PM: Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999, 340(3):197-206.
17. Capra V, Rovati GE: Leukotriene modifiers in asthma management. IDrugs 2004, 7(7):659-666.
18. Henderson JWR, Chiang GKS, Tien Y-t, Chi EY: Reversal of Allergen-induced Airway Remodeling by CysLT1 Receptor Blockade. Am J Respir Crit Care Med 2005 in press.
19. Ammit AJ, Panettieri RA Jr: Invited review: the circle of life: cell cycle regulation in airway smooth muscle. J Appl Physiol 2001, 91(3):1431-1437.
20. Brink C, Dahlen SE, Drazen J, Evans JF, Hay DW, Nicosia S, Serhan CN, Shimizu T, Yokomizo T: International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors. Pharmacol Rev 2003, 55(1):195-227.
21. Capra V: Molecular and functional aspects of human cysteinyl leukotriene receptors. Pharmacol Res 2004, 50(1):1-11.
22. Capra V, Accomazzo MR, Ravasi S, Parenti M, Macchia M, Nicosia S, Rovati GE: Involvement of prenylated proteins in calcium signaling induced by LTD4 in differentiated U937 cells. Prostaglandins Other Lipid Mediat 2003, 71(3-4):235-251.
23. Mellor EA, Frank N, Soler D, Hodge MR, Lora JM, Austen KF, Boyce JA: Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R. Proc Natl Acad Sci USA 2003.
24. Kenakin T: Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometry. Trends Pharmacol Sci 1997, 18(12):456-464.
25. Marinissen MJ, Gutkind JS: G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 2001, 22:368-376.
26. Capra V, Ravasi S, Accomazzo MR, Parenti M, Rovati GE: CysLT1 signal transduction in differentiated U937 cells involves the activation of the small GTP-binding protein Ras. Biochem Pharmacol 2004, 67(8):1569-1577.
27. Daub H, Weiss FU, Wallasch C, Ullrich A: Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 1996, 379(6565):557-560.
28. McMahon B, Mitchell D, Shattock R, Martin F, Brady HR, Godson C: Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation. FASEB J 2002, 16(13):1817-1819.
29. Zhou L, Hershenson MB: Mitogenic signaling pathways in airway smooth muscle. Respir Physiol Neurobiol 2003, 137(2-3):295-308.
30. Krymskaya VP, Orsini MJ, Eszterhas AJ, Brodbeck KC, Benovic JL, Panettieri RA Jr, Penn RB: Mechanisms of proliferation synergy by receptor tyrosine kinase and G protein-coupled receptor activation in human airway smooth muscle. Am J Respir Cell Mol Biol 2000, 23(4):546-554.
31. Capra V, Habib A, Accomazzo MR, Ravasi S, Citro S, Levy-Toledano S, Nicosia S, Rovati GE: Thromboxane prostanoid receptor in human airway smooth muscle cells: a relevant role in proliferation. Eur J Pharmacol 2003, 474(2-3):149-159.
32. Citro S, Ravasi S, Rovati GE, Capra V: Thromboxane prostanoid receptor signals through Gi protein to rapidly activate ERK in human airways. Am J Respir Cell Mol Biol 2005, 32:326-333.
33. Accomazzo MR, Rovati GE, Vigano T, Hernandez A, Bonazzi A, Bolla M, Fumagalli F, Viappiani S, Galbiati E, Ravasi S, et al.: Leukotriene D4-induced activation of smooth-muscle cells from human bronchi is partly Ca2+- independent. Am J Respir Crit Care Med 2001, 163(1):266-272.
34. 1 receptor. Nature 1999, 399:789-793.
35. Heise CE, O'Dowd BF, Figueroa DJ, Sawyer N, Nguyen T, Im D-S, Stocco R, Bellefeuille JN, Abramovitz M, Cheng R, et al.: Characterization of the Human Cysteinyl Leukotriene 2 Receptor. J Biol Chem 2000, 275(39):30531-30536.
36. Capra V, Nicosia S, Ragnini D, Mezzetti M, Keppler D, Rovati GE: Identification and characterization of two cysteinyl-leukotriene high affinity binding sites with receptor characteristics in human lung parenchyma. Mol Pharmacol 1998, 53(4):750-758.
37. Rovati GE: Ligand-binding studies: old beliefs and new strategies. Trends Pharmacol Sci 1998, 19(9):365-369.
38. Rovati GE, Giovanazzi S, Mezzetti M, Nicosia S: Heterogeneity of binding sites for ICI 198,615 in human lung parenchyma. Biochem Pharmacol 1992, 44(7):1411-1415.
39. McMahon B, Stenson C, McPhillips F, Fanning A, Brady HR, Godson C: Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors. J Biol Chem 2000, 275(36):27566-27575.
40. Paruchuri S, Hallberg B, Juhas M, Larsson C, Sjolander A: Leukotriene D(4) activates MAPK through a Ras-independent but PKCepsilon-dependent pathway in intestinal epithelial cells. J Cell Sci 2002, 115(Pt 9):1883-1893.
41. Orsini MJ, Krymskaya VP, Eszterhas AJ, Benovic JL, Panettieri RA Jr, Penn RB: MAPK superfamily activation in human airway smooth muscle: mitogenesis requires prolonged p42/p44 activation. Am J Physiol 1999, 277(3 Pt 1):L479-488.
42. Lee JH, Johnson PR, Roth M, Hunt NH, Black JL: ERK activation and mitogenesis in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2001, 280(5):L1019-1029.
43. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T: Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995, 270(5234):296-299.
44. Page K, Li J, Hodge JA, Liu PT, Vanden Hoek TL, Becker LB, Pestell RG, Rosner MR, Hershenson MB: Characterization of a Rac1 signaling pathway to cyclin D(1) expression in airway smooth muscle cells. J Biol Chem 1999, 274(31):22065-22071.
45. Henderson WR Jr, Tang L-O, Chu S-J, Tsao S-M, Chiang GKS, Jones F, Jonas M, Pae C, Wang H, Chi EY: A Role for Cysteinyl Leukotrienes in Airway Remodeling in a Mouse Asthma Model. Am J Respir Crit Care Med 2002, 165(1):108-116.
46. Vargaftig BB, Singer M: Leukotrienes mediate part of Ova-induced lung effects in mice via EGFR. Am J Physiol Lung Cell Mol Physiol 2003, 285(4):L808-818.
47. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, Ullrich A: EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHBEGF. Nature 1999, 402(6764):884-888.
48. Wymann MP, Zvelebil M, Laffargue M: Phosphoinositide 3-kinase signalling - which way to target? Trends Pharmacol Sci 2003, 24(7):366-376.
49. Krymskaya VP, Goncharova EA, Ammit AJ, Lim PN, Goncharov DA, Eszterhas A, Panettieri RA Jr: Src is necessary and sufficient for human airway smooth muscle cell proliferation and migration. FASEB J 2005, 19(3):428-430.
50. Shah BH, Olivares-Reyes JA, Catt KJ: The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H- indolo(2,3-a)py rrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor. Mol Pharmacol 2005, 67(1):184-194.
51. Wetzker R, Bohmer FD: Transactivation joins multiple tracks to the ERK/ MAPK cascade. Nat Rev Mol Cell Biol 2003, 4(8):651-657.
52. Pandya HC, Snetkov VA, Twort CH, Ward JP, Hirst SJ: Oxygen regulates mitogen-stimulated proliferation of fetal human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2002, 283(6):L1220-1230.
53. Kim JH, Chu SC, Gramlich JL, Pride YB, Babendreier E, Chauhan D, Salgia R, Podar K, Griffin JD, Sattler M: Activation of the PI3K/ mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species. Blood 2005, 105(4):1717-1723.
54. Weiss EB, Bellino JR: Leukotriene-associated toxic oxygen metabolites induce airway hyperreactivity. Chest 1986, 89(5):709-716.
55. Braga PC, Dal Sasso M, Dal Negro R: Inhibitory effects of zafirlukast on respiratory bursts of human neutrophils. Drugs Exp Clin Res 2002, 28(4):133-145.
56. Suzuki M, Kato M, Kimura H, Fujiu T, Morikawa A: Inhibition of human eosinophil activation by a cysteinyl leukotriene receptor antagonist (pranlukast; ONO-1078). J Asthma 2003, 40(4):395-404.
57. Blaukat A, Barac A, Cross MJ, Offermanns S, Dikic I: G protein-coupled receptor-mediated mitogen-activated protein kinase activation through cooperation of Galpha(q) and Galpha(i) signals. Mol Cell Biol 2000, 20(18):6837-6848.
58. Leikauf GD, Claesson HE, Doupnik CA, Hybbinette S, Grafstrom RC: Cysteinyl leukotrienes enhance growth of human airway epithelial cells. Am J Physiol 1990, 259(4 Pt 1):L255-261.